Industry
CBI files charge sheet against RCom, others in ₹3,750 crore LIC fraud case
What is happening to the Indian IT bench? | Explained
UPI volume jumps 27% to touch 145 bn in first half
FPIs turn net sellers, pull out ₹35,860 crore in September
Amazon expands ultra-fast delivery service to more than 120 Indian cities
Aurobindo Pharma wins U.S. FDA approval for generic asthma inhaler
The Hindu - Industry·15 Sep 2026
The product will be manufactured at subsidiary Aurolife Pharma’s Raleigh facility in North Carolina and expected to be launched in upcoming quarters.
More news in Industry
CBI files charge sheet against RCom, others in ₹3,750 crore LIC fraud caseWhat is happening to the Indian IT bench? | ExplainedUPI volume jumps 27% to touch 145 bn in first halfFPIs turn net sellers, pull out ₹35,860 crore in SeptemberAmazon expands ultra-fast delivery service to more than 120 Indian cities